Two main UK breast pathology reporting guidelines are published in June 2016:
1- Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer represents the update of the NHSBSP Guidelines for Pathology Reporting in Breast Cancer Screening and The Royal College of Pathologists’ Standards and datasets for reporting cancers 2005.
2- Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening: It replaces the Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening, 2001, and the previous guidelines published as NHSBSP Publication No 50.
The college website also provides breast dataset proformas (NHS BSP breast pathology synoptic proforma template for surgically resected lesions). These have been written to help breast pathologists work towards a consistent approach for the reporting and to define the range of acceptable practice in handling breast pathology specimens.
RCPath Pathology Documents Relevant to Breast Pathologists
1- Double-reporting in histopathology
2- Standards for integrated reporting in cellular pathology
3- Guidelines on staffing and workload for histopathology and cytopathology departments, 4th edition
4- An approach to the assessment of uncertainty of measurement for cellular pathology laboratories
This website provides guidelines produced by NICE (National Institute for Health and Care Excellence) on early and advanced breast cancer as well as familial breast cancer including management. It also provides other related guidelines, gene expression profiling and expanded IHC tests for guiding adjuvant chemotherapy, NICE Pathways, quality standards and advice. Of particular importance are the Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer (DG34) and the Early and locally advanced breast cancer: diagnosis and management (NG101).
Although this document describes the NHS breast cancer screening assessment guidelines, it covers B3 lesions, investigation and management (Page 13 and Appendix 2).2).
Nottingham Breast Pathology Database
These documents provide guidance for health professionals, managers and commissioners working in the NHS breast screening programme including programme guidance and standards, uncertainties about the management of women with screen-detected DCIS, higher risk women and the use of MRI, good practice in breast screening as well as equipment and quality control and quality assurance.
There are Quality Assurance Guidelines for Surgeons in Breast Cancer Screening (2009)
The ABS website includes variety of UK national guidelines. In recent years ABS has developed its Surgical Guidelines for the Management of Breast Cancer to ensure that treatment standards are the same regardless of whether patients were diagnosed through the NHS Breast Screening Programme or symptomatically. Recent guidelines include margin assessment (Invasive and DCIS), management of the axilla, and anaplastic large cell lymphoma guidelines.